Pfizer PFE
NYSE PFE
$29.24 -0.15 (-0.51%)
At close: Nov 9, 2026 · 4:00 PM EST

Pfizer (PFE) Gains (Losses) on Sale of Assets & Investments (2010 - 2020)

Updated

Analysis

Pfizer (PFE) Gains (Losses) on Sale of Assets & Investments (2010 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 139.96 Bn 111.95 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 29, 2020 6.00 Mn
Dec 31, 2019 20.00 Mn
Sep 29, 2019 8.09 Bn
Jul 1, 2012 17.00 Mn
Apr 1, 2012 7.00 Mn
Dec 31, 2011 -7.00 Mn
Oct 2, 2011 -18.00 Mn
Jul 3, 2011 14.00 Mn
Apr 3, 2011 12.00 Mn
Dec 31, 2010 19.00 Mn
Oct 3, 2010 13.00 Mn
Jul 4, 2010 185.00 Mn
Apr 4, 2010 45.00 Mn
API Access

Pfizer Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PFE&period=max&api_key=YOUR_API_KEY